SC

Suresh Chand Sharma

Active Director Director DIN 11484097
DIN 11484097 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Suresh Chand Sharma

Data last updated:

Suresh Chand Sharma is a Director at Vyom Health Sciences Private Limited (since 2026).

DIN 11484097
Primary Designation Director
First Appointment 14 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vyom Health Sciences Private Limited U85499DL2026PTC461675
Director14 Jan 20262026Active

Board colleagues of Suresh Chand Sharma

NameDINCompanyDesignation
Geeta11484096Vyom Health Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vyom Health Sciences Private Limited
Premium access

Shareholding and investment profile for Suresh Chand Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Chand Sharma

Suresh Chand Sharma currently holds 1 directorship: Vyom Health Sciences Private Limited (Director, since 14 Jan 2026).

Suresh Chand Sharma was first appointed on 14 Jan 2026 as Director at Vyom Health Sciences Private Limited.

The current boards of Suresh Chand Sharma's companies include Geeta (Vyom Health Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available